Cargando…

Neoadjuvant B-RAF and MEK Inhibitor Targeted Therapy for Adult Papillary Craniopharyngiomas: A New Treatment Paradigm

BACKGROUND: Surgical and clinical management of craniopharyngiomas is associated with high long-term morbidity especially in the case of hypothalamic involvement. Improvements in knowledge of craniopharyngioma molecular biology may offer the possibility of safe and effective medical neoadjuvant trea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Calvanese, Francesco, Jacquesson, Timothée, Manet, Romain, Vasiljevic, Alexandre, Lasolle, Hélène, Ducray, Francois, Raverot, Gerald, Jouanneau, Emmanuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228029/ https://www.ncbi.nlm.nih.gov/pubmed/35757402 http://dx.doi.org/10.3389/fendo.2022.882381

Ejemplares similares

Current Advances in Papillary Craniopharyngioma: State-Of-The-Art Therapies and Overview of the Literature
por: Jannelli, Gianpaolo, et al.
Publicado: (2023)

Aggressive corticotroph tumors and carcinomas
por: Lasolle, Hélène, et al.
Publicado: (2022)

The Challenging Management of Craniopharyngiomas in Adults: Time for a Reappraisal?
por: Cuny, Thomas, et al.
Publicado: (2022)

SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors
por: Castellnou, Solène, et al.
Publicado: (2020)

OR23-04 SST5 Expression and USP8 Mutation in Functioning and Silent Corticotroph Pituitary Tumors
por: castellnou, Solene, et al.
Publicado: (2020)

Craniopharyngioma in Adults
por: Zoicas, Flavius, et al.
Publicado: (2012)

Emerging and Novel Treatments for Pituitary Tumors
por: Ilie, Mirela Diana, et al.
Publicado: (2019)

Gonadotroph Tumors Show Subtype Differences that Might Have Implications for Therapy
por: Ilie, Mirela Diana, et al.
Publicado: (2020)

Sex-Related Differences in Lactotroph Tumor Aggressiveness Are Associated With a Specific Gene-Expression Signature and Genome Instability
por: Wierinckx, Anne, et al.
Publicado: (2018)

Treatment Strategies in Childhood Craniopharyngioma
por: Puget, Stéphanie
Publicado: (2012)

Surgical Strategies in Childhood Craniopharyngioma
por: Flitsch, Jörg, et al.
Publicado: (2011)

“RAF” neighborhood: Protein–protein interaction in the Raf/Mek/Erk pathway
por: Cseh, Botond, et al.
Publicado: (2014)

Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy
por: Rostami, Elham, et al.
Publicado: (2017)

Stereotactic Neurosurgical Treatment Options for Craniopharyngioma
por: Trippel, Michael, et al.
Publicado: (2012)

Intracystic Therapies for Cystic Craniopharyngioma in Childhood
por: Bartels, Ute, et al.
Publicado: (2012)

Diagnostics, Treatment, and Follow-Up in Craniopharyngioma
por: Müller, Hermann L.
Publicado: (2011)

Different Approaches in Radiation Therapy of Craniopharyngioma
por: Kortmann, Rolf-Dieter
Publicado: (2011)

Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis
por: Lasolle, Hélène, et al.
Publicado: (2020)

Mixed lineage kinases activate MEK independently of RAF to mediate resistance to RAF inhibitors
por: Marusiak, Anna A., et al.
Publicado: (2014)

Telemetric monitoring of intracystic pressure with sensor reservoir for recurrent sellar arachnoid cysts
por: Jannelli, Gianpaolo, et al.
Publicado: (2022)

Hypothalamic Obesity after Craniopharyngioma: Mechanisms, Diagnosis, and Treatment
por: Lustig, Robert H.
Publicado: (2011)

Craniopharyngioma – A Childhood and Adult Disease with Challenging Characteristics
por: Müller, Hermann L.
Publicado: (2012)

Conferring specificity on the ubiquitous Raf/MEK signalling pathway
por: O'Neill, E, et al.
Publicado: (2004)

Growth Inhibitory Signaling of the Raf/MEK/ERK Pathway
por: Wu, Pui-Kei, et al.
Publicado: (2020)

Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma
por: Guo, Ying, et al.
Publicado: (2023)

Clinical Implication of Individually Tailored Segmentation Method for Distorted Hypothalamus in Craniopharyngioma
por: Hong, A Ram, et al.
Publicado: (2021)

Tocilizumab for the fifth progression of cystic childhood craniopharyngioma—a case report
por: de Vos-Kerkhof, Evelien, et al.
Publicado: (2023)

Medical debulking with BRAF/MEK inhibitors in aggressive BRAF-mutant craniopharyngioma
por: Di Stefano, Anna Luisa, et al.
Publicado: (2020)

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
por: Atefi, Mohammad, et al.
Publicado: (2015)

The mechanism of activation of MEK1 by B-Raf and KSR1
por: Maloney, Ryan C., et al.
Publicado: (2022)

THU219 Vascular Damage After Craniopharyngioma
por: Beckhaus, Julia, et al.
Publicado: (2023)

Hypothalamic Obesity in Patients with Craniopharyngioma: Profound Changes of Several Weight Regulatory Circuits
por: Roth, Christian L.
Publicado: (2011)

Long Term Sequelae of Pediatric Craniopharyngioma – Literature Review and 20 Years of Experience
por: Cohen, Michal, et al.
Publicado: (2011)

Outcome of Endoscopy-Assisted Microscopic Extended Transsphenoidal Surgery for Suprasellar Adult Craniopharyngiomas
por: Ikeda, Hidetoshi, et al.
Publicado: (2012)

A Survey of Patient-Relevant Outcomes in Pediatric Craniopharyngioma: Focus on Hypothalamic Obesity
por: Craven, Meghan, et al.
Publicado: (2022)

Intratumoural spatial distribution of S100B + folliculostellate cells is associated with proliferation and expression of FSH and ERα in gonadotroph tumours
por: Ilie, Mirela Diana, et al.
Publicado: (2022)

PDCD6 cooperates with C-Raf to facilitate colorectal cancer progression via Raf/MEK/ERK activation
por: Wang, Xiaojuan, et al.
Publicado: (2020)

PLX8394, a RAF inhibitor, inhibits enterovirus 71 replication by blocking RAF/MEK/ERK signaling
por: Wu, Chengyuan, et al.
Publicado: (2023)

Overexpression of the pro‐protein convertase furin predicts prognosis and promotes papillary thyroid carcinoma progression and metastasis through RAF/MEK signaling
por: Poyil, Pratheesh Kumar, et al.
Publicado: (2023)

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas
por: Brastianos, Priscilla K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_v4svl4rotoa03cf41tdvampaj6